Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Appropriations

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Appropriations History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Appropriations ₹6,351 Cr₹4,681 Cr₹3,382 Cr₹2,738 Cr₹2,680 Cr

What is the latest Appropriations of NATCO PHARMA ?

The latest Appropriations ratio of NATCO PHARMA is ₹6,351 Cr based on Mar2025 Consolidated results.
Year Appropriations
Mar2025₹6,351 Cr
Mar2024₹4,681 Cr
Mar2023₹3,382 Cr
Mar2022₹2,738 Cr
Mar2021₹2,680 Cr

How is Appropriations of NATCO PHARMA Trending?

Years Appropriations % Change
Mar2025 ₹6,351 Cr
35.69
Mar2024 ₹4,681 Cr
38.40
Mar2023 ₹3,382 Cr
23.51
Mar2022 ₹2,738 Cr
2.17
Mar2021 ₹2,680 Cr -

Compare Appropriations of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,730.4 Cr 4.3% 6% -34.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,378.0 Cr 2.8% 6.7% 2.8% Stock Analytics
DIVIS LABORATORIES ₹171,996.0 Cr 1.9% -0.5% 6.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,959.0 Cr 0.1% 3.4% 15.8% Stock Analytics
CIPLA ₹123,666.0 Cr 1.8% -3.2% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,008.0 Cr 2.7% 0.4% 3.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

4.3%

6%

-34.9%

SENSEX

0.6%

1.3%

7%


You may also like the below Video Courses